Oncolytics Biotech Inc.
ONC.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -48.41% | -53.05% | -38.87% | -40.94% | -51.30% |
| Total Receivables | 1,452.50% | 1,119.15% | -49.61% | -95.40% | -17.80% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.81% | -18.40% | -24.71% | -5.32% | -42.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 21.17% | 84.48% |
| Total Current Assets | -41.79% | -44.97% | -40.52% | -38.10% | -47.83% |
|
|
|||||
| Total Current Assets | -41.79% | -44.97% | -40.52% | -38.10% | -47.83% |
| Net Property, Plant & Equipment | -20.26% | -25.08% | -27.68% | -24.67% | -16.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -40.46% | -43.51% | -39.81% | -37.50% | -46.59% |
|
|
|||||
| Total Accounts Payable | 394.65% | 363.49% | 18.89% | 50.74% | -1.35% |
| Total Accrued Expenses | -11.19% | -9.60% | -17.39% | 5.33% | 37.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.74% | -3.50% | 7.43% | 29.81% | 52.65% |
| Total Finance Division Other Current Liabilities | -- | -94.32% | -60.52% | -21.73% | 58.99% |
| Total Other Current Liabilities | -- | -94.32% | -60.52% | -21.73% | 58.99% |
| Total Current Liabilities | 35.14% | 24.89% | -3.10% | 7.23% | 32.44% |
|
|
|||||
| Total Current Liabilities | 35.14% | 24.89% | -3.10% | 7.23% | 32.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.77% | -34.05% | -33.55% | -32.76% | -29.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 60.74% | 4.98% | -3.01% | 0.35% | -5.79% |
| Total Liabilities | 44.64% | 12.43% | -4.69% | 1.28% | 5.62% |
|
|
|||||
| Common Stock & APIC | 25.38% | 5.48% | 2.30% | 4.17% | -2.87% |
| Retained Earnings | -30.19% | -7.18% | -4.27% | -6.98% | -0.76% |
| Treasury Stock & Other | 833.98% | -2.14% | 17.17% | 0.08% | 34.70% |
| Total Common Equity | -213.55% | -215.19% | -98.77% | -66.63% | -73.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -213.55% | -215.19% | -98.77% | -66.63% | -73.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -213.55% | -215.19% | -98.77% | -66.63% | -73.36% |
|
|
|||||